CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-24 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −7,505 | 45,447 | ||
| 2023-07-20 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −5,000 | $80.00 | $400K | 107,587 |
| 2023-06-29 | Lofton Kevin E Director | Grant or award · Phantom Stock | +30.91 | 3,163.26 | ||
| 2023-06-13 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −1,485 | $76.90 | $114K | 29,402 |
| 2023-06-10 | Patterson Sandra SVP, Controllership | Option exercise | +517 | 26,729 | ||
| 2023-06-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −153 | $78.12 | $12K | 26,576 |
| 2023-06-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −517 | 22,041 | ||
| 2023-06-10 | Parsey Merdad Chief Medical Officer | Option exercise | +2,779 | 32,181 | ||
| 2023-06-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −1,294 | $78.12 | $101K | 30,887 |
| 2023-06-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,779 | 46,533 | ||
| 2023-06-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +7,346 | 269,534 | ||
| 2023-06-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −3,409 | $78.12 | $266K | 266,125 |
| 2023-06-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −7,346 | 125,587 | ||
| 2023-06-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +2,730 | 45,267 | ||
| 2023-06-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,272 | $78.12 | $99K | 43,995 |
| 2023-06-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −2,730 | 52,952 | ||
| 2023-06-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +2,618 | 74,920 | ||
| 2023-06-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,219 | $78.12 | $95K | 73,701 |
| 2023-06-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,618 | 45,982 | ||
| 2023-05-03 | Kramer Kelly A. Director | Grant or award · Restricted Stock Unit | +1,887 | 15,284 |
Page 34 of 43 · 851 trades